For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Bluebird bio Inc’s stock clocked out at $0.36, up 3.31% from its previous closing price of $0.35. In other words, the price has increased by $3.31 from its previous closing price. On the day, 11.35 million shares were traded. BLUE stock price reached its highest trading level at $0.41 during the session, while it also had its lowest trading level at $0.35.
Ratios:
To gain a deeper understanding of BLUE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.33 and its Current Ratio is at 0.51.
On November 15, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $3 to $0.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 30 ’24 when Klima Thomas J sold 1,006 shares for $0.53 per share. The transaction valued at 529 led to the insider holds 170,000 shares of the business.
Obenshain Andrew sold 34,780 shares of BLUE for $18,270 on Sep 30 ’24. The President and CEO now owns 375,218 shares after completing the transaction at $0.53 per share. On Sep 30 ’24, another insider, Obenshain Andrew, who serves as the Officer of the company, bought 34,780 shares for $0.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 70330392 and an Enterprise Value of 321886080. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.56. Its current Enterprise Value per Revenue stands at 5.863 whereas that against EBITDA is -1.065.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $5.53, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -20.63%, while the 200-Day Moving Average is calculated to be -59.42%.
Shares Statistics:
It appears that BLUE traded 6.43M shares on average per day over the past three months and 5815360 shares per day over the past ten days. A total of 192.77M shares are outstanding, with a floating share count of 192.72M. Insiders hold about 0.89% of the company’s shares, while institutions hold 34.07% stake in the company. Shares short for BLUE as of 1730332800 were 47705814 with a Short Ratio of 7.42, compared to 1727654400 on 48991273. Therefore, it implies a Short% of Shares Outstanding of 47705814 and a Short% of Float of 26.66.
